Prednisone description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Prednisone

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

PREDNISONE DESCRIPTION


Prednisone






CLINICAL PHARMACOLOGY




INDICATIONS & USAGE


Endocrine disorders:
Rheumatic disorders:
Collagen diseases:
Dermatologic diseases:
Allergic states:
Ophthalmic diseases:
Respiratory diseases:
Hematologic disorders:
Neoplastic diseases:
Edematous states:
Gastrointestinal diseases:
Nervous system:
Miscellaneous:

PREDNISONE CONTRAINDICATIONS



WARNINGS






Usage in pregnancy





PRECAUTIONS

General Precautions








DOSAGE AND ADMINISTRATION.



DRUG INTERACTIONS




INFORMATION FOR PATIENTS



PREDNISONE ADVERSE REACTIONS

Fluid and electrolyte disturbances:
Musculoskeletal:
Gastrointestinal:
Dermatologic:
Metabolic:
Neurological:
Endocrine:
Ophthalmic:
Additional Reactions:

DOSAGE & ADMINISTRATION

IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT.

Multiple Sclerosis


Alternate Day Therapy

















HOW SUPPLIED







REFERENCES




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Prednisone

Prednisone

Prednisone

Prednisone TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-856(NDC:0591-5052)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
PREDNISONE PREDNISONE 5 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
SILICON DIOXIDE
CROSPOVIDONE
DOCUSATE SODIUM
MAGNESIUM STEARATE
SODIUM BENZOATE

Product Characteristics

Color Size Imprint Code Shape
white 6 mm DAN;DAN;5052 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-856-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA080356 2011-12-22


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.